Soluble CD 163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation
Open accessAbstract
Summary: Background: Activated hepatic macrophages play a key role in inflammation and fibrosis progression in chronic liver disease. Aim: To assess the prognostic value of soluble (s)CD 163 and mannose receptor (sMR) in cirrhotic patients and explore associations with markers of intestinal permeability (lactulose‐mannitol ratio, diamine oxidase), bacterial translocation (endotoxin, lipopolysaccharide‐binding protein) and markers of systemic immune activation (interleukin‐6, interleukin‐8, sCD 14). Methods: We prospectively investigated 101 cirrhotic patients (Child‐Pugh class A: n = 72, Child‐Pugh classes B and C: n = 29) and 31 healthy controls. Patients were observed for a median follow‐up of 37 months. Results: Median plasma levels of sCD163 and soluble mannose receptor were significantly elevated in cirrhotic patients (P < .001) and increased with disease severity (sCD163 in healthy controls = 1.3, Child‐Pugh class A = 4.2, Child‐Pugh classes B and C = 8.4 mg/L; sMR in healthy controls = 15.8, Child‐Pugh class A = 36.5, Child‐Pugh classes B and C = 66.3 μg/dL). A total of 21 patients died during the observation period. Patients with sCD163 levels above 5.9 mg/L showed significantly reduced survival (survival rate after 36 months: 71% versus 98%, P < .001). Patients with soluble mannose receptor levels above 45.5 μg/dL developed significantly more complications of cirrhosis within 12 months (73% versus 9%, P < .001). Furthermore, both variables correlated with the lactulose‐mannitol ratio, diamine oxidase, lipopolysaccharide and interleukin‐8. Conclusion: Our data demonstrate the prognostic value of sCD 163 in predicting long‐term survival in patients with liver cirrhosis and identify soluble mannose receptor as a prognostic marker for occurrence of cirrhosis‐associated complications. The correlation between gut barrier dysfunction and activation of macrophages points towards a link between them.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The gut may play an indispensable role in the progression of sepsis and multiple organ dysfunction, contributing to epithelial cell apoptosis and barrier impairment and promoting bacterial translocation.
“previous reports highlighted that the gut might play an indispensable role in the progression of sepsis and multiple organ dysfunction, contributing to epithelial cell apoptosis and barrier impairment and promoting bacterial translocation (Yang et al., 2019; Wang et al., 2015; Rainer et al., 2018; Bajaj et al., 2017).”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Rainer et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856 · see citing works
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016 · see citing works
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W. K., Therneau, T. M., Kosberg, C. L., D’Amico, G., Dickson, R. E., & Kim, W. R. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,989 · see citing works
D’Amico, G., García–Tsao, G., & Pagliaro, L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 3,195 · see citing works
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712 · see citing works
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · see citing works
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972 · see citing works
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971 · see citing works
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 815 · see citing works
Soluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bažil, V., Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1665 · Cited by 682 · see citing works
Martínez‐Pomares, L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512231 · Cited by 540 · see citing works
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488 · see citing works
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 472 · see citing works
Cavaillon, J. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90005-1 · Cited by 453 · see citing works
Bacterial translocation of enteric organisms in patients with cirrhosis
Cirera, I., Bauer, T., Navasa, M., Vilà, J., Grande, L., Taurá, P., Fuster, J., García‐Valdecasas, J. C., Lacy, A. M., Suárez, M. J., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00013-1 · Cited by 429 · see citing works
Fernando, M., Reyes, J. L., Iannuzzi, J. P., Leung, G., & McKay, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094188 · Cited by 316 · see citing works
Methods to determine intestinal permeability and bacterial translocation during liver disease
Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257 · see citing works
Liver architecture, cell function, and disease
Ishibashi, H., Nakamura, M., Komori, A., Migita, K., & Shimoda, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0155-6 · Cited by 192 · see citing works
The role of Kupffer cells in hepatitis B and hepatitis C virus infections.
Boltjes, A., Movita, D., Boonstra, A., & Woltman, A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.026 · Cited by 177 · see citing works
Kazankov, K., Francisco Barrera, M., Møller, H. J., Bibby, B. M., Vilstrup, H., George, J., & Grønbæk, H. (2014) · Hepatology · doi:10.1002/hep.27129 · Cited by 172 · see citing works
Self-citationCharacterization of an enzyme-linked immunosorbent assay for soluble CD163
Møller, H. J., Hald, K., & Moestrup, S. K. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102760145852 · Cited by 162 · see citing works
Self-citationGrønbæk, H., Sandahl, T. D., Mortensen, C., Vilstrup, H., Møller, H. J., & Møller, S. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05134.x · Cited by 148 · see citing works
Self-citationGrønbæk, H., Rødgaard‐Hansen, S., Aagaard, N. K., Arroyo, V., Moestrup, S. K., García, E., Solà, E., Domenicali, M., Piano, S. S., Vilstrup, H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.021 · Cited by 136 · see citing works
Self-citationHume, D. A., Underhill, D. M., Sweet, M. J., Ozinsky, A., Liew, F. Y., & Aderem, A. A. (2001) · BMC Immunology · doi:10.1186/1471-2172-2-11 · Cited by 126 · see citing works
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
Holland‐Fischer, P., Grønbæk, H., Sandahl, T. D., Moestrup, S. K., Riggio, O., Ridola, L., Aagaard, N. K., Møller, H. J., & Vilstrup, H. (2011) · Gut · doi:10.1136/gut.2010.234542 · Cited by 125 · see citing works
Self-citationHorvath, A., Leber, B., Schmerboeck, B., Tawdrous, M., Zettel, G., Hartl, A., Madl, T., Stryeck, S., Fuchs, D., Lemesch, S., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13788 · Cited by 118 · see citing works
Self-citationWaidmann, O., Brunner, F., Herrmann, E. M., Zeuzem, S., Piiper, A., & Kronenberger, B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.005 · Cited by 102 · see citing works
Rødgaard‐Hansen, S., Rafique, A., Christensen, P. A., Maniecki, M. B., Sandahl, T. D., Nexø, E., & Møller, H. J. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0451 · Cited by 97 · see citing works
Self-citationSandahl, T. D., Grønbæk, H., Møller, H. J., Støy, S. H., Thomsen, K. L., Dige, A. K., Agnholt, J. S., Hamilton-Dutoit, S. J., Thiel, S., & Vilstrup, H. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.262 · Cited by 96 · see citing works
Self-citationRegulation of macrophage activation in alcoholic liver disease
Thakur, V., McMullen, M. R., Pritchard, M. T., & Nagy, L. E. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04650.x · Cited by 93 · see citing works
The Scavenger Receptor CD163: Regulation, Promoter Structure and Genomic Organization
Ritter, M., Buechler, C., Langmann, T., Orsó, E., Klucken, J., & Schmitz, G. (1999) · Pathobiology · doi:10.1159/000028105 · Cited by 76 · see citing works
Waidmann, O., Köberle, V., Bettinger, D., Trojan, J., Zeuzem, S., Schultheiß, M., Kronenberger, B., & Piiper, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.008 · Cited by 72 · see citing works
Andersen, E. S., Rødgaard‐Hansen, S., Moessner, B. K., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1936-3 · Cited by 58 · see citing works
Hepatic macrophage activation predicts clinical decompensation in chronic liver disease
Rode, A., Nicoll, A., Møller, H. J., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304135 · Cited by 40 · see citing works
Self-citationDultz, G., Gerber, L., Farnik, H., et al. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12309 · Cited by 37 · see citing works
Funding, M., Vorum, H., Nexø, E., et al. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.00397.x · Cited by 26 · see citing works
Laursen, T. L., Rødgaard‐Hansen, S., Møller, H. J., et al. (2016) · Liver International · doi:10.1111/liv.13262 · Cited by 12 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [19]Child CG Turcotte JG Surgery and portal hypertension The Liver and Portal Hypertension Philadelphia Saunders 1964 50 64
Cited by
Sorted by citations
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354 · see citing works
Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
Stadlbauer, V., Engertsberger, L., Komarova, I., Feldbacher, N., Leber, B., Pichler, G., Fink, N., Scarpatetti, M., Schippinger, W., Schmidt, R., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01644-2 · Cited by 182 · see citing works
Self-citationEnteric dysbiosis is associated with sepsis in patients
Liu, Z., Li, N., Fang, H., Chen, X., Guo, Y., Gong, S., Niu, M., Zhou, H., Jiang, Y., Chang, P., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900398rr · Cited by 107 · see citing works
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56 · see citing works
Li, Z., Zhang, F., Sun, M., Liu, J., Zhao, L., Liu, S., Li, S., & Wang, B. (2023) · PeerJ · doi:10.7717/peerj.15122 · Cited by 43 · see citing works
- Authors
- Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., Møller, H. J., Grønbæk, H., & Stadlbauer, V.
- Affiliations
- Medical University of Graz (AT)
- Departments of Hepatology and Gastroenterology, and Clinical Biochemistry Denmark
- Corresponding author
- Rainer, F.
- ORCID
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-12-21
- Volume
- 47
- Issue
- 5
- Pages
- 657-664
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- PMC
- PMC6333289
- OpenAlex
- W2781085476
- Cited by
- 65
- References
- 37
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 14 · 2020: 10 · 2019: 4 · 2018: 5
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Austrian Science Fund (P 24362)
- Österreichische Forschungsförderungsgesellschaft (854419/6497141)
- Strategiske Forskningsråd (TRAIN 10‐092797)
- Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- liver cirrhosis, soluble CD163, hepatic macrophages, prognostic factors, survival, decompensation, intestinal permeability, bacterial translocation, lactulose/mannitol ratio, diamine oxidase, lipopolysaccharide, interleukin-8, systemic immune activation, intestinal barrier dysfunction, Child-Pugh score
- MeSH terms
- Mannose Receptor, CD163 Antigen, Aged, Female, Humans, Intestinal Mucosa, Intestines, Liver Cirrhosis, Male, Middle Aged, Permeability, Prognosis, Receptors, Cell Surface, Antigens, Differentiation, Myelomonocytic, Biomarkers, Antigens, CD, Case-Control Studies, Liver Failure, Bacterial Translocation, Lectins, C-Type, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review